we are talking about the medication hydroxychloroquine. They treat malaria, arthritis, red lupus, asthma. This is the drug which has the entire planet advertised the US President Donald trump, saying on Twitter that the drug showed promising results in the treatment of COVID‑19 and that he will be available to Americans. Medication is used during the SARS epidemic in 2002-2003, and tested it in Wuhan. The specialists, including representatives of the manufacturer of the medication, warning: information about a positive drug effect in patients with novel coronavirus infection really is, but its effectiveness is not yet proven as a full-blown, thoroughly research until it was. Now such studies are just beginning.
who named the most clear symptom of coronavirus
“who announced the start of an international clinical study on Solidarity in the evaluation of several drugs for the treatment of COVID‑19, including hydroxychloroquine. In Europe, also conducted a clinical study Discovery, which includes the use of this drug. In this study it is planned to include thousands of patients from different countries, including Belgium, the Netherlands, the United Kingdom, Germany, Spain and France”, – told “RG” Yuri Molchanov, Director of corporate Affairs at Sanofi Eurasia. This company was confirmed as “RG” in the DSM Group – the main supplier of the drug in Russia.
If you follow the rules, if the drug is not registered for use treatment of a particular disease, use it is impossible. But during a pandemic, and even when specific agents with proven efficacy against new andPeccei there, and people to protect and save it, not to hard constraints.
it is Possible, therefore, to participate in research on the use of medications offered and the Moscow physicians, at the initiative of the city Department of health.
When drugs with proven efficacy there, and people have to save, – there is no hard limit
As reported by “RG” in the contact center created in connection with the study, it is assumed that project participants will primarily be the medical staff of the hospitals, taking patients COVID‑19. The doctors declared their participation and have no contraindications to the drug, will receive it free for two weeks. It is clear, under the supervision of well-being. Parties with find contraindications, medicine to take and will not constitute a control group to evaluate the effectiveness of the drug.
Sobyanin explained the adoption of austerity measures in Moscow for coronavirus
“Particular attention should be paid to the protection of medical workers who are at increased risk of infection with novel coronavirus infection. In China at the beginning of March of 3,300 health workers were infected, and according to local media reports, by the end of February died at least 22 people. In Italy 20% of medical workers are infected.
the Aim of this open controlled study is to determine the efficacy and safety of hydroxychloroquine in the prevention of development of symptoms COVID‑19 health workers involved in the treatment and care of patients COVID‑19″, – stated on the resource that you created for online registration of doctors who want to participate in the study.
